The report "Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) - Global Forecast to 2027" The Global Endoscope Reprocessing Market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven by increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities.
Browse 213 market data Tables and 53 Figures spread through 267 Pages and in-depth TOC on "Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) - Global Forecast to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/endoscope-reprocessing-market-219094994.html
Automated Endoscope Reprocessors are expected to accounted the highest CAGR of the endoscope reprocessing market, by product in 2021.
Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2021, the automated endoscope reprocessors (AERs) segment holds the highest CAGR of the global endoscope reprocessing market. The highest CAGR of this segment is due to The increasing adoption of automated endoscope reprocessors in hospitals for endoscope reprocessing, the rising number of endoscopy procedures, the increasing development of novel automated endoscope reprocessors, and the rising geriatric population are expected to drive the market for AERs.
Hospitals are expected to accounted the highest CAGR of the endoscope reprocessing market, by end user in 2021.
Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2021, the hospitals segment has the highest CAGR due increasing number of endoscopic surgeries performed has resulted in the increasing incidence of infections caused due to endoscopes. This has compelled hospitals to install endoscope reprocessing units.
Asia Pacific accounted the highest CAGR of the endoscope reprocessing market in 2021.
Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, Asia Pacific has the highest CAGR of the endoscope reprocessing market. The highest CAGR of Asia Pacific can be attributed to factors such as is driven by the growing awareness of early disease diagnosis in developing countries and the rising technological advancements in endoscope reprocessing. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the endoscope reprocessing market.
The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), Medalkan (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441